Purity Sitagliptin Phosphate Monohydrate Powder Sitagliptin Intermediate Pharmaceutical Chemical Sitagliptin

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung Sitagliptin
• Product Name: Sitagliptin
• Name: Sitagliptin Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Diabetes
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 486460-32-6
• Mf: C16h15f6n5o
• MW: 407.31400
• Density: 1.614G/Cm3
• Melting Point: 114.1-115.7 C
• Boiling Point: 529.905 C at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 3 Ton/Month

Product Description

Purity Sitagliptin Phosphate Monohydrate Powder Sitagliptin Intermediate Pharmaceutical Chemical Sitagliptin

 

Product Description

Product Details

Product Name	Sitagliptin
CAS No.	486460-32-6
MF	C16H15F6N5O
MW	407.31400
Appearance and shape	White powder

Sitagliptin is very effective in the treatment of type 2 diabetes. As a new type of anti-diabetic drug, Sitagliptin has the advantages of blood sugar dependence, moderate hypoglycemic effect, no hypoglycemia while increasing  secretion, effectively reducing hunger, and no nausea, vomiting, edema and weight gain. and other side effects. An anti-diabetic (antihyperglycemic) drug of the dipeptidyl peptidase-4 (DPP-4) class. Inhibition of the enzyme DPP-4 is thought to increase Glucagon-like peptide-1 (GLP-1) which inhibits glucagon release , stimulates the release and lowers blood glucose.
Sitagliptin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.

Application & Function

Function of Sitagliptin
Sitagliptin is a new type of anti-type II diabetes drug approved by the FDA and the first dipeptidyl peptidase-IV inhibitor drug for the treatment of type II diabetes.Sitagliptin's mechanism of action is different from previous oral hypoglycemic drugs.
Application of Sitagliptin
Sitagliptin is an oral antihyperglycemic of the dipeptidyl peptidase-4  inhibitor class. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents for treatment of diabetes mellitus type 2.The benefit of this medicine is its fewer side effects in the control of blood glucose values.While safety is its advantage, efficacy is often challenged as it is often recommended to be combined with other agents such as metformin.

Specification